Aigen Investment Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.18M | Sell |
15,032
-9,058
| -38% | -$708K | 0.16% | 203 |
|
|
2025
Q1 | $1.75M | Buy |
+24,090
| New | +$1.75M | 0.28% | 100 |
|
|
2024
Q2 | – | Sell |
-4,532
| Closed | -$433K | – | 855 |
|
|
2024
Q1 | $433K | Buy |
+4,532
| New | +$433K | 0.09% | 321 |
|
|
2023
Q1 | – | Sell |
-98,859
| Closed | -$7.38M | – | 680 |
|
|
2022
Q4 | $7.38M | Buy |
+98,859
| New | +$7.38M | 1.04% | 16 |
|
|
2022
Q1 | – | Sell |
-10,042
| Closed | -$1.27M | – | 711 |
|
|
2021
Q4 | $1.27M | Buy |
+10,042
| New | +$1.27M | 0.08% | 341 |
|
|
2021
Q2 | – | Sell |
-3,010
| Closed | -$252K | – | 554 |
|
|
2021
Q1 | $252K | Buy |
+3,010
| New | +$252K | 0.03% | 469 |
|
|
2020
Q4 | – | Sell |
-3,420
| Closed | -$273K | – | 849 |
|
|
2020
Q3 | $273K | Sell |
3,420
-15,838
| -82% | -$1.26M | 0.03% | 568 |
|
|
2020
Q2 | $1.33M | Sell |
19,258
-16,199
| -46% | -$1.12M | 0.17% | 177 |
|
|
2020
Q1 | $2.23M | Buy |
35,457
+34,743
| +4,866% | +$2.18M | 0.3% | 76 |
|
|
2019
Q4 | $56K | Buy |
+714
| New | +$56K | 0.01% | 794 |
|